NCT01265641View on ClinicalTrials.gov

To Investigate the Effects of AZD1981 on the QT Interval

PHASE1CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Asthma

Interventions

DRUG

AZD1981, 2000mg

Single oral dose, tablets

DRUG

AZD1981, 200mg

Single oral dose, tablets

DRUG

Moxifloxacin, 400mg

Single oral dose, capsule

DRUG

Placebo

Single oral dose, tablets

Trial Locations (1)

Unknown

Researche Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY